Literature DB >> 11422741

Connective tissue growth factor in tubulointerstitial injury of diabetic nephropathy.

S Wang1, M Denichilo, C Brubaker, R Hirschberg.   

Abstract

BACKGROUND: Chronic interstitial fibrosis, which follows the onset of glomerular proteinuria, importantly contributes to progressive renal failure in diabetic nephropathy. The present studies examine the potential role of tubular connective tissue growth factor (CTGF).
METHODS: The expression of CTGF was examined in rats with diabetic nephropathy. Regulation and actions of CTGF were studied in in vitro cell culture models.
RESULTS: CTGF mRNA levels were increased in the renal cortex of rats with streptozotocin-induced diabetes compared with controls. Immunohistology indicated that CTGF was expressed in renal cortex of diabetic rats, in contrast to controls in some tubular cross-sections, particularly dilated-appearing proximal tubules, in which it tended to colocalize with insulin-like growth factor-I (IGF-I). Glomerular ultrafiltrate from diabetic rats, which contained bioactive transforming growth factor-beta (TGF-beta) and hepatocyte growth factor (HGF), induced increased CTGF expression in tubular cells. TGF-beta1 and, to a lesser extent, HGF also raised CTGF expression in cultured proximal tubular cells. In contrast, high glucose (25 mmol/L) did not increase the secretion of CTGF. In cultured tubular cells, rhCTGF moderately increased fibronectin but not collagen (Col) type I and type III expression. In NRK-49F renal interstitial fibroblasts, CTGF raised Col alpha1III and thrombospondin-1 levels. CTGF has an IGF-binding domain and binds to IGF-I. In NRK-49F cells, IGF-I increased the activity of CTGF towards the expression of Col alpha1III.
CONCLUSIONS: CTGF is expressed and regulated downstream from TGF-beta and HGF in proximal tubular cells, is induced by diabetic rat glomerular ultrafiltrate, and has moderate profibrogenic activity in tubular cells and renal interstitial fibroblasts, where its activity is IGF-I dependent. By these means, CTGF may act downstream of TGF-beta and HGF and may contribute to chronic tubulointerstitial fibrosis in diabetic nephropathy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11422741     DOI: 10.1046/j.1523-1755.2001.00776.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  56 in total

1.  The time has come to target connective tissue growth factor in diabetic complications.

Authors:  S M Twigg; M E Cooper
Journal:  Diabetologia       Date:  2004-05-28       Impact factor: 10.122

2.  Low-density lipoprotein induced expression of connective tissue growth factor via transactivation of sphingosine 1-phosphate receptors in mesangial cells.

Authors:  Hesham M El-Shewy; Mimi Sohn; Parker Wilson; Mi Hye Lee; Samar M Hammad; Louis M Luttrell; Ayad A Jaffa
Journal:  Mol Endocrinol       Date:  2012-03-15

Review 3.  Cardiometabolic syndrome and chronic kidney disease.

Authors:  Guido Lastra; Camila Manrique; Samy I McFarlane; James R Sowers
Journal:  Curr Diab Rep       Date:  2006-06       Impact factor: 4.810

Review 4.  A glimpse of various pathogenetic mechanisms of diabetic nephropathy.

Authors:  Yashpal S Kanwar; Lin Sun; Ping Xie; Fu-You Liu; Sheldon Chen
Journal:  Annu Rev Pathol       Date:  2011       Impact factor: 23.472

5.  alpha2-antiplasmin is associated with the progression of fibrosis.

Authors:  Yosuke Kanno; Eri Kawashita; Misato Minamida; Aki Kaneiwa; Kiyotaka Okada; Shigeru Ueshima; Osamu Matsuo; Hiroyuki Matsuno
Journal:  Am J Pathol       Date:  2009-12-11       Impact factor: 4.307

6.  Differential expression of connective tissue growth factor in microglia and pericytes in the human diabetic retina.

Authors:  E J Kuiper; A N Witmer; I Klaassen; N Oliver; R Goldschmeding; R O Schlingemann
Journal:  Br J Ophthalmol       Date:  2004-08       Impact factor: 4.638

7.  Connective tissue growth factor(CCN2), a pathogenic factor in diabetic nephropathy. What does it do? How does it do it?

Authors:  Roger M Mason
Journal:  J Cell Commun Signal       Date:  2009-02-14       Impact factor: 5.782

Review 8.  Therapeutic targets for treating fibrotic kidney diseases.

Authors:  So-Young Lee; Sung I Kim; Mary E Choi
Journal:  Transl Res       Date:  2014-08-13       Impact factor: 7.012

9.  Angiotensin II increases connective tissue growth factor in the kidney.

Authors:  Monica Rupérez; Marta Ruiz-Ortega; Vanesa Esteban; Oscar Lorenzo; Sergio Mezzano; Juan Jose Plaza; Jesús Egido
Journal:  Am J Pathol       Date:  2003-11       Impact factor: 4.307

10.  Connective tissue growth factor is necessary for retinal capillary basal lamina thickening in diabetic mice.

Authors:  Esther J Kuiper; Rogier van Zijderveld; Peggy Roestenberg; Karen M Lyons; Roel Goldschmeding; Ingeborg Klaassen; Cornelis J F Van Noorden; Reinier O Schlingemann
Journal:  J Histochem Cytochem       Date:  2008-05-12       Impact factor: 2.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.